Rg. Dluhy, CLINICAL RELEVANCE OF INHALED CORTICOSTEROIDS AND HPA AXIS SUPPRESSION, Journal of allergy and clinical immunology, 101(4), 1998, pp. 447-450
Although hypothalamic-pituitary-adrenal (HPA) asis suppression has tra
ditionally been viewed as an adverse event after long-term administrat
ion of corticosteroids, this effect can also be used to compare the po
tency of different inhaled corticosteroids. However, various factors s
uch as the dose, frequency of administration, treatment duration, stud
y population (patients with asthma versus normal volunteers), and prio
r systemic steroid therapy influence adrenal suppression with inhaled
corticosteroids. The different adrenal function tests available and th
e results produced with these tests also must be considered along with
the clinical relevance of such results. Whereas low doses of inhaled
corticosteroids are likely to cause minimal or no HPA asis suppression
, longterm high-dose inhaled corticosteroid use may result in signific
ant suppression by effectively replacing endogenous steroid production
. The risk of acute adrenal insufficiency in patients taking low/mediu
m-dose inhaled corticosteroids is minimal, but patients receiving long
-term high-dose treatment may require supplementary systemic steroids
during stress challenges, especially if they have previously received
long-term systemic steroid treatment.